ABcann Medicinals Inc (ABCN)

[Stevo7965]

Home
News
Policy
Featured Companies
Thought Leaders
Conferences
Industry Reports
Contact
Become A Featured Company
ABcann: A Compelling Value After Going Public

inShare

Ryan Allway

May 16th, 2017

Feature Stories, News

Canada’s cannabis industry could be worth upwards of $22.6 billion over the coming years, while many analysts are predicting a shortfall in supply. As a result, licensed producers have become an attractive investment opportunity, with many approaching C$1 billion valuations over the past several quarters. Investors may want to take a look beyond the headline licensed producers toward newer entrants to the market that have only recently gone public.

In this article, we will take a look at ABcann Global Corp. (TSXV: ABCN) (OTC: ABCCF) following its going-public transaction and why investors may want to consider investing.

Attractive Comparable Valuation

There are about 40 licensed producers that have received approval from Health Canada to cultivate and sell medical cannabis to consumers. The largest company in the space is Canopy Growth Corp. (TSX: WEED), which has become the first cannabis ‘unicorn’ with a valuation that’s well over C$1 billion. Many other licensed producers are close to achieving these kinds of valuations as they ramp up production and revenue.

Company Name Ticker Symbol Market Capitalization
Canopy Growth Corp. TSX: WEED C$1.37 Billion
Aurora Cannabis Inc. CA: ACB C$844.48 Million
Aphria Inc. CA: APH C$815.19 Million
Organigram Holdings Inc. CA: OGI C$258.55 Million
Supreme Pharmaceuticals Inc. CNX: SL C$243.74 Million
* Data as of May 10, 2017.

ABcann Global is attractively priced by comparison with a market capitalization of about C$85 million, despite being one of the first licensed producers approved by Health Canada in 2014. The company hasn’t scaled up its production as quickly as other LPs, but it has signed high-profile partnerships with companies like Syqe Medical Inc. – the innovator behind the first metered dosage inhaler – and developed some of the highest yields in the industry.

In addition, the company has the cash on hand to significantly expand its capacity over the near-term. Management anticipates that its Van Luven facility will double its capacity, to about 29.000 square feet, this year while the Kimmet facility will come online next year with a 150,000 square foot presence.

Experienced Management Team

ABcann Global has an experienced management team that’s well-positioned to execute on plans to become a leader in the space.

Chairman Ken Clement has developed a strong rapport with Health Canada and cultivated several strategic partnerships around the world. His goal of standardizing production and doses of cannabinoids has help shaped the company’s unique focus relative to other licensed producers that are focused on simply maximizing production of commoditized products that will eventually be hard to compete against as the market grows.

CEO Aaron Keay has over 10 years of experience across many different sectors, serving in corporate finance, senior management, and board member roles. With a history of raising over $250 million, Mr. Keay is well-positioned to help the company secure funding and grow. Mr. Keay is also joined by a seasoned executive management team with experience across areas of management, finance, and the operation of cannabis businesses.

Finally, the company has developed a solid board of advisors that includes the ‘father of cannabis’, Dr. Raphael Mechoulam, Ph.D. Dr. Mechoulam is an organic chemist and professor of Medicinal Chemistry at the Hebrew University of Jerusalem. He’s best known for being the first scientist to isolate tetrahydrocannabinol (THC) and then cannabidiol (CBD) in 1963. Dr. Mechoulam is joined by many other prominent researchers and scientists in the field.

Rapidly Growing Market

Canada’s cannabis industry could be worth between $12.7 billion and $22.6 billion by 2020, according to Deloitte Canada, eclipsing the combined sales of beer, wine, and spirits. The country is widely expected to implement recreational legalization by early next year, which could open the market significantly beyond the medical users that are currently served under the Access to Cannabis for Medical Purposes Regulations – or ACMPR.

PI Financial believes that there could be a shortfall in supply with only about 40 companies licensed by Health Canada to grow and sell the drug. According to a recent report, the analyst reckons that LPs would need to cultivate a total of 610,000 kilograms to fulfill domestic and export demand by 2019. The problem is that existing capacity would fall short and lead to a 200,000 kilogram shortfall and it could be difficult to onboard enough new LPs.

“The rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry and there will be a shortfall in supply in a legalized market in the short-term until production capacities catch up by 2020,” said Canaccord Genuity Group analysts in a November 2016 research note. This could create an enormous opportunity for existing licensed producers that enjoy an oligopoly of sorts.

Looking Ahead

ABcann Global Corp. (TSXV: ABCN) (OTC: ABCCF) represents a compelling investment opportunity in Canada’s burgeoning cannabis industry. With a focus on standardization and dosing, the company is developing a competitive edge in the medicinal side of the industry while building out its production capacity and its high-yield strategies. Investors may want to keep an eye on the stock following its going-public transaction on May 4.

For more information, visit the company’s corporate website at www.abcannglobal.com.

Ryan Allway
About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist.
Search CannabisFN

Press Coverage


Marijuana Index

Marijuana Index Global 464.27 0.12

Today 5d 1m 3m 1y
Visit the Marijuana Index
Discover Cannabis Investments
Sign-up for our free cannabis investment newsletter to discover the latest opportunities in the space.

Name
E-Mail Address

Visit the CFN Video Library
Join Our Facebook Page
Top Videos

Daniel Yazbeck of MyDx Inc.
Daniel Yazbeck of MyDx Inc.
In this interview, CFN’s Mike Elliott speaks with MyDx Inc. CEO Daniel Yazbek about the company’s affordable portable analyzer that provides real-time chemical analyses and fits in the palm of the hand. MyDx Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California, whose mission is to help people Trust & Verify™ […]

Leslie Bocskor of Electrum Partners
Leslie Bocskor of Electrum Partners
In this recent video with Leslie Bocskor, Founder of Electrum Partners, Dan Wise explores what’s been happening at Electrum Partners over the last year. The interview focuses on the wealth of experience Electrum Partners provides in business services, strategic advice, and license procurement in the cannabis industry.

Invictus MD Strategies Corp.
Invictus MD Strategies Corp.
Invictus MD targets companies with proven brands, strong customer focus, and significant growth potential.

One World Cannabis, Ltd.
One World Cannabis, Ltd.
One World Cannabis Ltd. is an Israeli-based company founded in 2014 by a group of professionals with expertise in the field of medical cannabis treatment and medical cannabis regulatory affairs. The company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of various medical conditions.

Network Partners

Hemp Business Journal

CWCB Expo

Viridian

Fresh Toast

TNM News

Follow Us on Social Media

Facebook
LinkedIn
Twitter
About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer